Tag: dolutegravir

Strides Pharma’s HIV generic drug gets tentative FDA approval

businessnewstoday- September 14, 2023

Strides Pharma Science Limited (Strides) announced that its Singapore-based stepdown wholly owned subsidiary, Strides Pharma Global Pte. Limited, has received tentative approval for Dolutegravir 50mg ... Read More

Aurobindo Pharma gets tentative FDA approval for generic HIV treatment for children

businessnewstoday- August 16, 2023

Aurobindo Pharma Limited has achieved a significant milestone by securing the US Food and Drug Administration (FDA)'s tentative nod under the PEPFAR program for its ... Read More

FDA grants tentative approval to Lupin for Dolutegravir, Lamivudine, and Tenofovir Alafenamide Tablets

businessnewstoday- July 21, 2023

Lupin Limited, a leading global pharmaceutical company, has received tentative approval for its New Drug Application (NDA) for Dolutegravir Lamivudine and Tenofovir Alafenamide Tablets from ... Read More

Lupin gains tentative FDA approval for Dolutegravir Tablets generic

businessnewstoday- July 5, 2023

Indian pharmaceutical company Lupin announced that the US Food and Drug Administration (FDA) has granted tentative approval for its Abbreviated New Drug Application (ANDA) for ... Read More

Lupin Limited gets FDA tentative approval for HIV drug cocktail TLD

pallavi123- July 1, 2021

Lupin Limited has been granted tentative approval by the US Food and Drug Administration (FDA) for its new drug application (NDA) for HIV drug cocktail ... Read More

ViiV Healthcare secures Dovato EMA approval for HIV-1 treatment

pharmanewsdaily- July 14, 2019

Dovato EMA approval : The European Commission (EC) has approved ViiV Healthcare’s once-daily, single-pill, two-drug regimen Dovato (dolutegravir/lamivudine) for the treatment of human immunodeficiency virus ... Read More